Somnigroup International shares are down about 3.31% to $70.95 as traders rotate out of highly levered consumer discretionary names and reprice execution risk from the Mattress Firm acquisition. Recent company guidance for 2026 adjusted EPS of $3.00–$3.40 has kept sensitivity high to any signs of softer demand or slower synergy capture, especially after prior revenue-miss headlines around results even when EPS held up.

The Mattress Firm acquisition materially expanded scale, but it also left investors focused on debt and the path to deleveraging. Management has highlighted synergy and marketing initiatives post-acquisition, yet the market continues to trade the stock as a “show-me” story where any incremental concern about consumer demand, promotional intensity, or cost pressures can quickly hit sentiment versus the company’s 2026 outlook range.

Another layer of uncertainty is the Leggett & Platt situation: Leggett & Platt previously disclosed it entered a non-disclosure agreement and a six-month standstill with Somnigroup to facilitate due diligence and explore whether a transaction could be reached, after rejecting Somnigroup’s $12-per-share proposal as undervaluing the company. With no assurance a deal happens—or on what terms—investors can treat the process as an asymmetric risk: either SGI walks away (limited strategic upside) or pursues a transaction that could raise financing and integration questions.

Key near-term swing factors are (1) any updated commentary on leverage reduction and cash generation, (2) evidence that Mattress Firm synergies and merchandising/marketing changes are translating into sustained comps and margins through 2026, and (3) any new developments on Leggett & Platt discussions within the standstill period. If none emerge, SGI may trade mainly on macro consumer signals and rates-driven views on levered balance sheets.